IndraLab

Statements

Bortezomib inhibits TRAF6. 7 / 7
| 7
reach
"These results illustrate that bortezomib can inhibit the activation of TRAF6 and NF-kappaB activity in SAS cells."
29703234
reach
"Cytotoxic effects of bortezomib in myelodysplastic syndrome and acute myeloid leukemia depend on autophagy mediated lysosomal degradation of TRAF6 and repression of PSMA1."
22685174
reach
"Paradoxically, we find that bortezomib induces proteasome independent degradation of the TRAF6 protein, but not mRNA, in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) cell lines and primary cells."
22685174
reach
"Bortezomib inhibits activation of TRAF6 and NF-kappaB activity."
29703234
reach
"It has been reported that bortezomib can induce proteasome independent degradation of TRAF6 in myelodysplastic syndrome [XREF_BIBR]."
29703234
reach
"To determine whether degradation of TRAF6 by bortezomib occurs via UPS, a proteasome inhibitor (MG132) was evaluated."
29703234
reach
"Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6."
18778854